Smith & Nephew plc
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; t… Read more
Market Cap & Net Worth: Smith & Nephew plc (SNNUF)
Smith & Nephew plc (PINK:SNNUF) has a market capitalization of $12.16 Billion ($12.16 Billion) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #1440 globally and #1095 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Smith & Nephew plc's stock price $14.33 by its total outstanding shares 848912138 (848.91 Million).
Smith & Nephew plc Market Cap History: 2015 to 2025
Smith & Nephew plc's market capitalization history from 2015 to 2025. Data shows growth from $12.63 Billion to $12.16 Billion (0.04% CAGR).
Smith & Nephew plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Smith & Nephew plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.89x
Smith & Nephew plc's market cap is 1.89 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
26.62x
Smith & Nephew plc's market cap is 26.62 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $12.63 Billion | $4.63 Billion | $410.00 Million | 2.73x | 30.81x |
| 2016 | $10.35 Billion | $4.67 Billion | $784.00 Million | 2.22x | 13.20x |
| 2017 | $12.19 Billion | $4.76 Billion | $767.00 Million | 2.56x | 15.90x |
| 2018 | $13.04 Billion | $4.90 Billion | $663.00 Million | 2.66x | 19.67x |
| 2019 | $17.74 Billion | $5.14 Billion | $600.00 Million | 3.45x | 29.57x |
| 2020 | $16.19 Billion | $4.56 Billion | $448.00 Million | 3.55x | 36.15x |
| 2021 | $13.03 Billion | $5.21 Billion | $524.00 Million | 2.50x | 24.86x |
| 2022 | $10.67 Billion | $5.21 Billion | $223.00 Million | 2.05x | 47.85x |
| 2023 | $11.41 Billion | $5.55 Billion | $263.00 Million | 2.06x | 43.38x |
| 2024 | $10.97 Billion | $5.81 Billion | $412.00 Million | 1.89x | 26.62x |
Competitor Companies of SNNUF by Market Capitalization
Companies near Smith & Nephew plc in the global market cap rankings as of March 19, 2026.
Key companies related to Smith & Nephew plc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Smith & Nephew plc Historical Marketcap From 2015 to 2025
Between 2015 and today, Smith & Nephew plc's market cap moved from $12.63 Billion to $ 12.16 Billion, with a yearly change of 0.04%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $12.16 Billion | +10.91% |
| 2024 | $10.97 Billion | -3.87% |
| 2023 | $11.41 Billion | +6.92% |
| 2022 | $10.67 Billion | -18.09% |
| 2021 | $13.03 Billion | -19.56% |
| 2020 | $16.19 Billion | -8.73% |
| 2019 | $17.74 Billion | +36.09% |
| 2018 | $13.04 Billion | +6.92% |
| 2017 | $12.19 Billion | +17.84% |
| 2016 | $10.35 Billion | -18.09% |
| 2015 | $12.63 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Smith & Nephew plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.16 Billion USD |
| MoneyControl | $12.16 Billion USD |
| MarketWatch | $12.16 Billion USD |
| marketcap.company | $12.16 Billion USD |
| Reuters | $12.16 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.